Feb 2 (Reuters) - The U.S. health regulator said on Wednesday that it had approved the first generic version of AbbVie Inc's (ABBV.N), opens new tab Restasis, a treatment used in increasing tear ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback